Product Details
Molecular Formula
C18H18N3NaO3S
Molecular Weight
379.40859
Appearance
Crystalline powder
Grade
Pharmaceutical grade
Description
Rosiglitazone sodium is the sodium salt form of rosiglitazone, functioning as the active pharmaceutical ingredient (API) in the thiazolidinedione class of antidiabetic agents. Its primary mechanism of action is as a potent and selective agonist for the peroxisome proliferator-activated receptor-gamma (PPAR-纬), which enhances insulin sensitivity in adipose tissue, muscle, and the liver, thereby reducing blood glucose levels with minimal direct effect on insulin secretion.
Stability and Storage Conditions
Hygroscopic
Solubility
Soluble in water and slightly soluble to sparingly soluble in common organic solvents
Storage
Sealed in dry,Room Temperature
Applications
The Rosiglitazone sodium is used in the manufacture of oral dosage forms (primarily tablets) for the treatment of type 2 diabetes mellitus. Its clinical application is as an adjunct to diet and exercise to improve glycemic control, typically in combination with other antidiabetic agents like metformin or sulfonylureas when monotherapy provides insufficient control.
SMILES
N1([Na])C(=O)C(CC2C=CC(=CC=2)OCCN(C)C2=CC=CC=N2)SC1=O
InChI
InChI=1S/C18H19N3O3S.Na/c1-21(16-4-2-3-9-19-16)10-11-24-14-7-5-13(6-8-14)12-15-17(22)20-18(23)25-15;/h2-9,15H,10-12H2,1H3,(H,20,22,23);/q;+1/p-1
Water Solubility
Soluble in water
InChI Key
XFOHHIYSRDUSCX-UHFFFAOYSA-M